NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

393 hedge funds and large institutions have $8.65B invested in Neurocrine Biosciences in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 137 increasing their positions, 156 reducing their positions, and 44 closing their positions.

Holders
393
Holders Change
-13
Holders Change %
-3.2%
% of All Funds
6.9%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
35
Increased
137
Reduced
156
Closed
44
Calls
$89.4M
Puts
$36.3M
Net Calls
+$53.1M
Net Calls Change
+$23.9M

Top Buyers

1
PAMS
1
Pictet Asset Management (Switzerland)
Switzerland
$129M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$258M
3
EVM
3
Eaton Vance Management
Massachusetts
$181M
4
DM
4
Deerfield Management
New York
$110M
5
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$71.1M

Top Sellers

1
Invesco
1
Invesco
Georgia
$31.4M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$332M
3
Capital International Investors
3
Capital International Investors
California
$42.9M
4
Rockefeller Capital Management
4
Rockefeller Capital Management
New York
$2.05M
5
ACH
5
ArrowMark Colorado Holdings
Colorado
$2.5M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$980M 10,218,233 +79,736 +0.8%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$862M 8,986,311 +34,237 +0.4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$852M 8,888,470 -96,151 -1%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$428M 4,464,285 -564,974 -11%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$332M 3,465,147 -763,211 -18%
State Street
6
State Street
Massachusetts
$332M 3,461,068 +47,735 +1%
BG
7
Bellevue Group
Switzerland
$288M 3,004,051 -13,700 -0.5%
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$258M 2,689,498 +1,242,324 +86%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$182M 1,902,047 -113,584 -6%
EVM
10
Eaton Vance Management
Massachusetts
$181M 1,885,906 +652,772 +53%
DCP
11
DSM Capital Partners
Florida
$145M 1,513,110 -22,374 -1%
Goldman Sachs
12
Goldman Sachs
New York
$138M 1,443,498 +20,210 +1%
Renaissance Technologies
13
Renaissance Technologies
New York
$130M 1,355,964 +113,241 +9%
PAMS
14
Pictet Asset Management (Switzerland)
Switzerland
$129M 1,349,850 +1,349,850 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$116M 1,212,221 +9,087 +0.8%
O
16
OrbiMed
New York
$114M 1,192,015 -39,100 -3%
DM
17
Deerfield Management
New York
$110M 1,142,415 +417,415 +58%
RSCM
18
Rock Springs Capital Management
Maryland
$101M 1,051,500 +36,500 +4%
CAM
19
Congress Asset Management
Massachusetts
$97M 1,011,772 +63,207 +7%
Franklin Resources
20
Franklin Resources
California
$92.5M 964,024 +1,490 +0.2%
Northern Trust
21
Northern Trust
Illinois
$87.6M 913,799 +17,940 +2%
PHS
22
PFM Health Sciences
California
$82.9M 864,079 -251,925 -23%
APM
23
Avidity Partners Management
Texas
$81.4M 848,900 +167,900 +25%
Citadel Advisors
24
Citadel Advisors
Florida
$80.9M 844,001 +176,015 +26%
Brown Advisory
25
Brown Advisory
Maryland
$76.1M 793,007 +14,661 +2%
1
2 3 4 5